TITLE

Analysis of Michigan Medicaid Costs to Treat HIV Infection

AUTHOR(S)

Solomon, David J.; Hogan, Andrew J.; Bouknight, Reynard A.; Solomon, Carolyn T.

PUB. DATE

September 1989

SOURCE

Public Health Reports;Sep/Oct89, Vol. 104 Issue 5, p416

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

To obtain better understanding of the nature and cost of health care related to human immunodeficiency virus (HIV) infection, medical payment records were analyzed for 204 men, women, and children older than 60 months who had indications of HIV infection. The records were those of Michigan Medicaid, the General Assistance Medical Program, and the Resident County Hospitalization Program, with service dates on or after January 1, 1984, and which were processed by November 30, 1987. Patient payment records were coded according to whether the patient's condition was considered to be pre-HIV, HIV unrelated, possibly HIV related, or HIV related. Average monthly payments were found to be $150 for pre-HIV patient payment records, $114 for those HIV unrelated, $57 for those possibly related, and $1,213 for those related to HIV infection. HI V-related monthly payments rose from about $1,500 per month in the period 3 months prior to the patient's death to more than $8,000 in the last month of life. Men were found to have twice as many claims as women, and men's claims cost about three times as much. A higher percentage of women than men (91 percent versus 37 percent) received pre-HIV paid services, indicating a higher percentage of women were at least initially receiving Medicaid for reasons other than an HIV-related disability. Diagnostic categories that accounted for the bulk of the HI V-related health care utilization included infectious and parasitic diseases, acquired immunodeficiency syndrome, diseases of the respiratory system, and non-HI V-specific immunity disorders. Inpatient hospitalization accounted for more than 75 percent of the payments, followed by physician costs (11 percent), pharmacy costs (5 percent), and outpatient costs (3 percent). A total of 45, or about 22 percent of the recipients, received zidovudine (AZT) prescriptions at an average monthly cost of $404.

ACCESSION #

24449194

Tags: HIV infections;  MEDICAL care costs;  MEDICAID;  AIDS (Disease);  HIV (Viruses)

 

Related Articles

• Management of HIV infection and other related issues.  // Drug Store News;8/24/98, Vol. 20 Issue 13, pCP59 

  No abstract available.

• HIV/AIDS not just a Third World issue. Rozycki, Bob // Fairfield County Business Journal;8/7/2006, Vol. 45 Issue 32, p15 

  The article discusses the issue regarding cases of AIDS and human immunodeficiency virus (HIV) infections in Fairfield County, Connecticut. Accordingly, these viruses infects people from all walks of life either professional, black and white people. In Fairfield County, HIV became the subject of...

• International Nurses Day 2003 FIGHTING THE STIGMA OF HIV/AIDS. Armstrong, Fiona // Australian Nursing Journal;May2003, Vol. 10 Issue 10, p22 

  Provides information on dealing with HIV and AIDS disease. Fear and discrimination associated with HIV/AIDS infection; Effects of the AIDS problems in Africa; HIV infection rates in Australia from 1999 to 2001. INSET: HIV/AIDS: World round up.

• The Acquired Immunodeficiency Syndrome (AIDS) and Infection with the Human Immunodeficiency Virus (HIV).  // Annals of Internal Medicine;Mar88, Vol. 108 Issue 3, p460 

  Provides information on AIDS and infection with HIV. Overview of AIDS in the U.S.; Impact of AIDS on the economy; Risk of transmission of HIV infection from patients to health care worker.

• Reducing heterosexual transmission of HIV in poor countries. Lamptey, Peter R // BMJ: British Medical Journal (International Edition);01/26/2002, Vol. 324 Issue 7331, p207 

  Presents a study which describes the impact of the HIV/AIDS pandemic on health and its economic and social impact in poor countries. Methods; Impact of HIV/AIDS on populations; Heterosexual transmission of HIV; How decreasing the risk of infection may slow the epidemic; Way that the treatment...

• Patterns of infection: using age prevalence data to understand the epidemic of HIV in South Africa. Williams, B.G.; Gouws, E.; Colvin, M.; Ramjee, G.; Abdool Karim, S.S.; Sitas, F. // South African Journal of Science;Jun2000, Vol. 96 Issue 6, p305 

  South Africa is experiencing an explosive epidemic of HIV/AIDS, with about one in four women attending ante-natal clinics nationwide being HIV-positive. In order to understand the natural history of the epidemic, to design and target interventions to manage it and to evaluate the impact of...

• The early years of HIV research: integrating clinical and basic research. Barre-Sinoussi, Francoise // Nature Medicine;Jul2003, Vol. 9 Issue 7, p844 

  Between the first analysis of patient samples in early 1983 and the determination of the sequence of HIV-1 in 1985, a vast amount of data was accumulated on HIV through the integrated efforts of clinicians, virologists, immunologists, molecular biologists and epidemiologists. These early years...

• HIV and AIDS: 20 years of science. Fauci, Anthony S // Nature Medicine;Jul2003, Vol. 9 Issue 7, p839 

  From the identification of HIV as the agent that causes AIDS, to the development of effective antiretroviral drugs, the scientific achievements in HIV research in the past 20 years have been formidable. Some of the other important areas of accomplishment include the development of blood tests...

• Twenty years on.  // Nature Medicine;Jul2003, Vol. 9 Issue 7, p838 

  Introduces the special issue of 'Nature Medicine' commemorating 20 years of HIV science. Institutions engaged in conducting or funding HIV/AIDS rsearch and prevention; Advances in HIV science since 1983.

Read the Article